Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

5 structures for Q9WVB3

Entry ID Method Resolution Chain Position Source
8H93 EM 301 A B/E 1-581 PDB
8H94 EM 290 A B 1-581 PDB
8H95 EM 338 A B 1-581 PDB
8H96 EM 278 A B 1-581 PDB
AF-Q9WVB3-F1 Predicted AlphaFoldDB

44 variants for Q9WVB3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs219364929 9 D>G No EVA
rs236406753 27 V>M No EVA
rs3389118863 33 E>D No EVA
rs1134547162 36 S>R No EVA
rs245637112 46 E>D No EVA
rs3389118014 52 A>V No EVA
rs3389116368 66 P>A No EVA
rs260965875 78 V>L No EVA
rs241330430 81 E>G No EVA
rs3389117530 83 D>N No EVA
rs221043952 95 M>T No EVA
rs3389059520 125 S>G No EVA
rs221865789 137 F>C No EVA
rs260775092 158 C>Y No EVA
rs3389095383 183 G>S No EVA
rs3389118078 196 C>S No EVA
rs3389122259 205 R>G No EVA
rs3389095401 231 E>K No EVA
rs3389116390 232 D>Y No EVA
rs211867574 244 S>F No EVA
rs3389113664 253 P>S No EVA
rs3389110301 264 S>I No EVA
rs261820155 271 A>P No EVA
rs3389117523 273 W>* No EVA
rs3389117568 282 Q>H No EVA
rs3389095325 325 V>M No EVA
rs247535140 336 K>Q No EVA
rs3412564209 347 R>P No EVA
rs3389122283 370 V>L No EVA
rs264674341 402 A>T No EVA
rs3389059505 440 D>V No EVA
rs3389095396 453 C>W No EVA
rs3389128219 472 M>I No EVA
rs3389118883 485 L>Q No EVA
rs3401527943 486 G>V No EVA
rs3401480921 489 N>I No EVA
rs3389084424 494 L>M No EVA
rs212768799 498 R>S No EVA
rs221859166 531 G>A No EVA
rs221859166 531 G>D No EVA
rs50131868 531 G>S No EVA
rs3389118924 560 T>I No EVA
rs50096865 563 G>S No EVA
rs3389084408 567 I>F No EVA

No associated diseases with Q9WVB3

4 regional properties for Q9WVB3

Type Name Position InterPro Accession
repeat WD40 repeat 283 - 320 IPR001680-1
repeat WD40 repeat 377 - 455 IPR001680-2
repeat WD40 repeat 499 - 538 IPR001680-3
repeat WD40 repeat 541 - 578 IPR001680-4

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • In the subcortical cytoplasm of early embryos from the 1-cell to the blastocyst stages (PubMed:18804437, PubMed:25208553)
  • At the 2-cell and morular stage, still detected in the subcortex, but excluded from cell-cell contact regions (PubMed:18804437, PubMed:25208553)
  • Expression largely disappears in blastocysts (PubMed:25208553)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
cell cortex The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
subcortical maternal complex Comprised of at least NLRP5, OOEP, TLE6, and KHDC3/KHDC3L with evidence of additional SCMC-associated proteins that interact with one or multiple members of the core complex.
transcription regulator complex A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.

1 GO annotations of molecular function

Name Definition
transcription corepressor activity A transcription coregulator activity that represses or decreases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Corepressors often act by altering chromatin structure and modifications. For example, one class of transcription corepressors modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators.

12 GO annotations of biological process

Name Definition
actin filament organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.
embryonic process involved in female pregnancy A reproductive process occurring in the embryo or fetus that allows the embryo or fetus to develop within the mother.
endoplasmic reticulum localization Any process in which endoplasmic reticulum is transported to, and/or maintained in, a specific location within the cell.
establishment of spindle localization The directed movement of the spindle to a specific location in the cell.
mitochondrion localization Any process in which a mitochondrion or mitochondria are transported to, and/or maintained in, a specific location within the cell.
negative regulation of canonical Wnt signaling pathway Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of embryonic development Any process that activates or increases the frequency, rate or extent of embryonic development.
positive regulation of neurogenesis Any process that activates or increases the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
positive regulation of neuron differentiation Any process that activates or increases the frequency, rate or extent of neuron differentiation.
regulation of cell division Any process that modulates the frequency, rate or extent of the physical partitioning and separation of a cell into daughter cells.
spermatogonial cell division The mitotic divisions of the primary spermatogonial cell (a primordial male germ cell) to form secondary spermatogonia (primary spermatocytes).

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9H808 TLE6 Transducin-like enhancer protein 6 Homo sapiens (Human) PR
10 20 30 40 50 60
MTSHRQSSDT FGGILPSTLS SRYLSIVNQL PEEFSSVVSE MMVHLENIFS LAENFFQAIE
70 80 90 100 110 120
RFSRTPDLLE RNKMSIGVGA EGDSWPCHVS HEAPMGSAQT TENSAKEEDK QVPESAALQH
130 140 150 160 170 180
PKFKSTPGPQ LPTRRRFLSE SDELQDPQPV WDAEPQFCQG FLIQGLWELF MDSRQKNQQE
190 200 210 220 230 240
HGGEDSSQES KDSGLCDFKP EPQPRHRNSL SDSADPFLIK SPSALLDYYQ EDVSRPQPET
250 260 270 280 290 300
QESSGRADKF LKPLSWGSEV LESSCNQPST ALWQLERFTV PQALQKVRVL KHQELLLVVA
310 320 330 340 350 360
VSSFTRHVFT CSQSGIKVWN LVNQVAEDRD PESHLKCSVQ DNKVYLRTCL LSSNSRTLFA
370 380 390 400 410 420
GGYNLPGVIV WDLAAPSLYE KCQLPCEGLS CQALANTKEN MALAGFTDGT VRIWDLRTQE
430 440 450 460 470 480
IVRNLKGPTN SARNLVVKDD NIWTGGLDAC LRCWDLRMAK VSLEHLFQSQ IMSLAHSPTE
490 500 510 520 530 540
DWLLLGLANG QHCLFNSRKR DQVLTVDTKD NTILGLKFSP NGKWWASVGM GNFITVHSMP
550 560 570 580
TGAKLFQVPE VGPVRCFDMT ENGRLIITGS RDCASVYHIK Y